Following the announcement of positive results from Janssen’s Phase III open-label long-term extension study, whic...
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, has announced that the Com...
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity a...
Luye Pharma announced that its new investigational drug, Rotigotine Extended Release Microspheres for Injection (LY03003...
The Global Health Innovative Technology (GHIT) Fund has announced a total of 520 million yen ($4.6 million) to support f...
The Global Antibiotic Research and Development Partnership (GARDP), Eisai Co., Ltd. and Takeda Pharmaceutical Company Li...
China-based HitGen announced that the company has entered into a drug discovery research collaboration with Mitsubishi T...
Mundipharma and Hisamitsu Pharmaceutical have agreed that Hisamitsu Pharmaceutical will end distribution of dermally abs...
The Union Cabinet chaired by Prime Minister Narendra Modi today has given its ex-post facto approval on the Memoran...
Daiichi Sankyo Company, Limited announced that updated efficacy and safety results from the ongoing phase 1/2 study...
AGC Inc., a world-leading manufacturer of glass, chemicals and high-tech materials, has announced that it has entered in...
VSee, the telehealth company behind NASA International Space Station, Walgreens, MDLIVE, DaVita, Trinity, Ascension and ...
Researchers have developed a way to grow human platelets in the laboratory from stem cells derived from fat tissue. Thes...
Sun Pharmaceutical, recently announced that it has entered into a definitive agreement to acquire Pola Pharma Inc. (&ldq...
Singapore - The fact that Japanese people have the longest lifespan in the world—and that they live healthier well...
Ono Pharmaceutical announced today that ONO has submitted in Japan an application for manufacturing and marketing ...
Daiichi Sankyo Company, Limited has launched the antitumor agent trastuzumab Biosimilar for intravenous drip infusions 6...
Sysmex Corporation, a Japanese in vitro diagnostics company, and MolecularMD Corporation, a US based molecular diagnosti...
